CA1212641A - Ice nucleating microorganisms - Google Patents
Ice nucleating microorganismsInfo
- Publication number
- CA1212641A CA1212641A CA000430877A CA430877A CA1212641A CA 1212641 A CA1212641 A CA 1212641A CA 000430877 A CA000430877 A CA 000430877A CA 430877 A CA430877 A CA 430877A CA 1212641 A CA1212641 A CA 1212641A
- Authority
- CA
- Canada
- Prior art keywords
- cell
- dna sequence
- ice nucleation
- microorganism
- ina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
NOVEL ICE NUCLEATING MICROORGANISMS
ABSTRACT OF THE DISCLOSURE
DNA sequences encoding for ice nucleation activity are isolated and introduced into unicellular hosts. The modified hosts demonstrate ice nucleation activity analogous to the DNA source host. The cellular products find use in inhibiting supercooling.
ABSTRACT OF THE DISCLOSURE
DNA sequences encoding for ice nucleation activity are isolated and introduced into unicellular hosts. The modified hosts demonstrate ice nucleation activity analogous to the DNA source host. The cellular products find use in inhibiting supercooling.
Description
~Z6~L
This invention relates to a cell with enhanced ice nucleation property and to a method of enhanciny the ice nucleation properties oE a cell.
Genetic evolution ha.s aforded an extraordinary array of biological capabilities in nature. The variou~
organisms or cells achieve these di~ferent functions by producing a wide variety of proteins, many of which in turn can produce a wide variety of non-proteinaceous molecules. These naturally occurring compounds can interact with their environment modifying the environment for good and bad.
It has been found that certain organisms are capable of nucleating the formation of ice Ice nucleation is of substantial commercial interest as a factor in inducting frost injury to plants, ln atmospheric precipitation processes and in commercial sno~making. Therefore, the ability to control the ice nucleating capability of micxoorganisms or to produce products having such nucleation capability can be employed in a wide range of agricultural, commercial, recreational or environmental situations. The ice nucleating microorganisms can be used for preventing supercooling of water, in snowmaking machines, in ice rinks, or other situations where supercooling is energy inefficient.
A variety of papers have been published con-cerning the effect of bacteria on ice nucleation. See, for example, Lindow et al., Proc. Am Phytopathol. Soc.
(1977) 4.1976:169; Arny et al., Nature (1976) 262~282~283; Lindow et al. Phytophathology (1978) 68:523-528; Lindow et al., Appl. Environ. Microbiol.
(1978) 36:831-838; Lindow et al., Proc. Am. Phytopathol.
Soc. (1977) 3.1976:224. See also, U.S. Patent Nos.
4,045,910, 4,161,084, 4,200,228 and 4,432,160.
L2~
This invention relates to a cell with enhanced ice nucleation property and to a method of enhanciny the ice nucleation properties oE a cell.
Genetic evolution ha.s aforded an extraordinary array of biological capabilities in nature. The variou~
organisms or cells achieve these di~ferent functions by producing a wide variety of proteins, many of which in turn can produce a wide variety of non-proteinaceous molecules. These naturally occurring compounds can interact with their environment modifying the environment for good and bad.
It has been found that certain organisms are capable of nucleating the formation of ice Ice nucleation is of substantial commercial interest as a factor in inducting frost injury to plants, ln atmospheric precipitation processes and in commercial sno~making. Therefore, the ability to control the ice nucleating capability of micxoorganisms or to produce products having such nucleation capability can be employed in a wide range of agricultural, commercial, recreational or environmental situations. The ice nucleating microorganisms can be used for preventing supercooling of water, in snowmaking machines, in ice rinks, or other situations where supercooling is energy inefficient.
A variety of papers have been published con-cerning the effect of bacteria on ice nucleation. See, for example, Lindow et al., Proc. Am Phytopathol. Soc.
(1977) 4.1976:169; Arny et al., Nature (1976) 262~282~283; Lindow et al. Phytophathology (1978) 68:523-528; Lindow et al., Appl. Environ. Microbiol.
(1978) 36:831-838; Lindow et al., Proc. Am. Phytopathol.
Soc. (1977) 3.1976:224. See also, U.S. Patent Nos.
4,045,910, 4,161,084, 4,200,228 and 4,432,160.
L2~
2 -This invention provides DNA sequences encoding for substances having ice nucleation activity, The se~uences are capable of being cloned in a host foreigrl to khe source of the DNA
sequence and imparting ice nucleation activity to such host.
DNA sequences, plasmids and transformants are described.
The subject invention provides for the isolation of DNA segments encoding for ice nucleation activity (I~A), which DNA segments may be introduced into an appropriate vector. ~he v~ctor may be a plasmid, virus or other self-replicating extrachromosomal element which may be used for conjugation, transformation, transduction, or transfection for introduction of the INA activity into a unicellular microorganism host. The hos~ may then be grown and cloned and INA clones isolated. The INA positive clones or sub-cellular portions or extracts derived from them may be used for ice nucleation in snowmaking (see U.S. Patent No.
4,200,228~j as a source of the protein(s) encoded by the INA
encoding gene(s), as a source of other cellular substances resulting from the expression of said gene(s), or in other situations where water supercooling is undesirable.
In order to obtain the DNA sequence encoding for INA, an organism known to provide for ice nucleation may be employed. Conveniently, various species of Pseudomonas, such as syr~ , coronafaciens, pisi, tabaci or fluor-escens, Xanthomonas, Xanthomonas~ such as translucens, or Erwinia, such as herbicola, or other organism having ice nucleation activity may be employed as a source for the preparation of a genomic library. Various restriction enzymes may be employed which provide for segments of up to 25kb by complete or incomplete digestion. These fragments may then be cloned.
Various vectors may be employed having different specificities. Plasmids, viruses, or cosmids may be emplo-yed, which allow for insertion of the fragments from the 3L2~
genomic library to provide a functional ~elf-replicating extrachromosomal elemen~. Therefore, the vector should hav~
a convenient restriction site or one should be able to introduce such site, which allows for a c~nvenient insertion of the genomic library fragments. Desirably, the vector should provide a means for selection and/or screening, through antibiotic selection, packaging requirements, inacti-~ation of a gene, or o-ther means.
Of particular interest is a cosmid vector, more particularly pLAFRl, which has a unique EcoRI site. This vector is a derivative of the vector pRK290 (Tcr) that contains the cos sites of phage A for ln vitro packaging.
It is a broad host range oligocopy vector, where the unique EcoRI site is outside the Tc gene~ There is no selection or screening for insertional inactivation in pRK290, however, the pLAFRl derivative is very useful because packaging selects for inserts automatically, where the inserts are of about 20kb ~lOkb in length.
Depending upon the choice of vector, the DNA
sequence encoding for INA may be introduced into a wide variety of unicellular microorganism hosts, including bac-teria, fungi, yeast, algae, protozoa, and the like. The choice of host will depend upon the availability of a vector, the purpose for introducing the INA into the host, and the manner in which the host is to be used. Depending upon the nature of the vector, various techniques may be used for introducing the vector plus a DNA insert into the host. Transformation can be achieved in conventional ways employing calcium precipitated ~NA in an appropriate sol-vent. Transfection may be achieved by contacting cells innutrient medium with a modified virus or its DNA to cause transfection or transduction of the cells depending upon integration of the sequence encoding INA. Conjugation can also be employed, where the plasmid is introduced into one organism, which may then transfer the plasmid to a different organism either being capable of mobilization by itself or in conjunction with a mobilizing plasmid.
~2~2~
In isolating the organisms receiving the exogenous DNA from the genomic library, it is desirable to use a I2JA
organism, wherehy a resulting clone which is s~own to be INA is likely to have had a DNA sequence encoding for INA
introduced into the organism. Many organisms do not natu-rally have I~A capability, so that any clones which show ice nucleation capability would have had to have received the DNA encoding for INA.
Now that it has been shown that the yenes encoding for INA can be transferred to organisms which had previously not shown ice nucleation capability, these oryanisms can now be used for screening DNA segments for INA activity. The clones can be screened by a simple technique where colonies plated on appropriate solid nutrient media are transferred to velvet pads which are replica-printed onto sheets of aluminum foil precoated with a thin layer of paraffin. By placing the sheets onto the surface of a circulating alcohol bath precooled to temperatures below zero and atomizing water over the sheets, so that microdroplets contact the cells, INA cells freeze the microdroplets and give a frosty appearance to INA+ colonies~ In this manner, INA colonies can be identified.
It is found that the genes encoding INA activity-can be located on a single fragment of less than about lOkb.
Thus, it is found that the genes involved with INA are not distributed at a number of different sites in the chromo-some, nor does the product encoded by such genes require for INA activity the specific nature of the membrane associated with naturally occurring microorganisms having ice nucleat-ing activity. Furthermore, ice nucleating capability isgreatly enhanced by employing a multicopy vector, so that it appears that the ice nucleating activity is associated with enhanced expression of the genes encoding for the INA.
In order to demonstrate the subject invention, the following experiments were carried out.
EXPERIMENTAL
. . .
Methods Three strains were employed as sources for DNA
encoding for INA: Pseudomonas syringae (two strains:c.it-7 and 31rif-1) and Erwlnla herbicola (one skrain:26SR6~2).
The DNA from the strains was extracted, purified by two cycles of CsCl-ethidium bromide density gxadient centrifuga-tion, freed of ethidium bromide, dialyzed against appro-priate buffers, partially digested with EcoRI and frac~
tionated by a 5-25 neutral sucrose gradient centrifugation.
The partial digestion employed 0.3 units EcoRI per l~g DNA
following the directions of the supplier (Bethesda, Research Laboratories, Md.) and the reaction ~uenched after 0.5hr by heating at 65C for 2min. Fractions obtained from the sucrose gradient were analyzed by agarose gel electrophor-esis and those rich in fragments in the 18-25kb range were pooled and ligated to the cosmid vector pLAFRl, previously linearized with EcoRI. (pL~FR was supplied by S. Long).
The plasmid pLAFRl is a derivative of the vector pRK290 (Tcr) that contains the cos sites of phage A for ln vitro packaging. pLAFRl was obtained by inserting a BglII
fragment from pHC79 (Hohn and Collins, Gene (1980) 11:291-298) into th~ BglII site of pRK290. The plasmid is-a broad host range oligocopy vector with a single EcoRI site outside the Tc gene. There is no selection or screening for insertional inactivation in pRK290. However, the pLAFR1 derivative is very useful because it requires inserts of a minimum size for packaging and therefore selects automa-tically for inserts of about 18-30kb in length.
Ligation of the DNA fragments in pLAFRl is achieved using T4 ligase following the supplier's directions (Bethesda Research Labs.). A relatively high ratio of foxeign DN~ fragments to linearized vector i~ employed, about 3-4:1/ to minimize dimerization of the vector. About
sequence and imparting ice nucleation activity to such host.
DNA sequences, plasmids and transformants are described.
The subject invention provides for the isolation of DNA segments encoding for ice nucleation activity (I~A), which DNA segments may be introduced into an appropriate vector. ~he v~ctor may be a plasmid, virus or other self-replicating extrachromosomal element which may be used for conjugation, transformation, transduction, or transfection for introduction of the INA activity into a unicellular microorganism host. The hos~ may then be grown and cloned and INA clones isolated. The INA positive clones or sub-cellular portions or extracts derived from them may be used for ice nucleation in snowmaking (see U.S. Patent No.
4,200,228~j as a source of the protein(s) encoded by the INA
encoding gene(s), as a source of other cellular substances resulting from the expression of said gene(s), or in other situations where water supercooling is undesirable.
In order to obtain the DNA sequence encoding for INA, an organism known to provide for ice nucleation may be employed. Conveniently, various species of Pseudomonas, such as syr~ , coronafaciens, pisi, tabaci or fluor-escens, Xanthomonas, Xanthomonas~ such as translucens, or Erwinia, such as herbicola, or other organism having ice nucleation activity may be employed as a source for the preparation of a genomic library. Various restriction enzymes may be employed which provide for segments of up to 25kb by complete or incomplete digestion. These fragments may then be cloned.
Various vectors may be employed having different specificities. Plasmids, viruses, or cosmids may be emplo-yed, which allow for insertion of the fragments from the 3L2~
genomic library to provide a functional ~elf-replicating extrachromosomal elemen~. Therefore, the vector should hav~
a convenient restriction site or one should be able to introduce such site, which allows for a c~nvenient insertion of the genomic library fragments. Desirably, the vector should provide a means for selection and/or screening, through antibiotic selection, packaging requirements, inacti-~ation of a gene, or o-ther means.
Of particular interest is a cosmid vector, more particularly pLAFRl, which has a unique EcoRI site. This vector is a derivative of the vector pRK290 (Tcr) that contains the cos sites of phage A for ln vitro packaging.
It is a broad host range oligocopy vector, where the unique EcoRI site is outside the Tc gene~ There is no selection or screening for insertional inactivation in pRK290, however, the pLAFRl derivative is very useful because packaging selects for inserts automatically, where the inserts are of about 20kb ~lOkb in length.
Depending upon the choice of vector, the DNA
sequence encoding for INA may be introduced into a wide variety of unicellular microorganism hosts, including bac-teria, fungi, yeast, algae, protozoa, and the like. The choice of host will depend upon the availability of a vector, the purpose for introducing the INA into the host, and the manner in which the host is to be used. Depending upon the nature of the vector, various techniques may be used for introducing the vector plus a DNA insert into the host. Transformation can be achieved in conventional ways employing calcium precipitated ~NA in an appropriate sol-vent. Transfection may be achieved by contacting cells innutrient medium with a modified virus or its DNA to cause transfection or transduction of the cells depending upon integration of the sequence encoding INA. Conjugation can also be employed, where the plasmid is introduced into one organism, which may then transfer the plasmid to a different organism either being capable of mobilization by itself or in conjunction with a mobilizing plasmid.
~2~2~
In isolating the organisms receiving the exogenous DNA from the genomic library, it is desirable to use a I2JA
organism, wherehy a resulting clone which is s~own to be INA is likely to have had a DNA sequence encoding for INA
introduced into the organism. Many organisms do not natu-rally have I~A capability, so that any clones which show ice nucleation capability would have had to have received the DNA encoding for INA.
Now that it has been shown that the yenes encoding for INA can be transferred to organisms which had previously not shown ice nucleation capability, these oryanisms can now be used for screening DNA segments for INA activity. The clones can be screened by a simple technique where colonies plated on appropriate solid nutrient media are transferred to velvet pads which are replica-printed onto sheets of aluminum foil precoated with a thin layer of paraffin. By placing the sheets onto the surface of a circulating alcohol bath precooled to temperatures below zero and atomizing water over the sheets, so that microdroplets contact the cells, INA cells freeze the microdroplets and give a frosty appearance to INA+ colonies~ In this manner, INA colonies can be identified.
It is found that the genes encoding INA activity-can be located on a single fragment of less than about lOkb.
Thus, it is found that the genes involved with INA are not distributed at a number of different sites in the chromo-some, nor does the product encoded by such genes require for INA activity the specific nature of the membrane associated with naturally occurring microorganisms having ice nucleat-ing activity. Furthermore, ice nucleating capability isgreatly enhanced by employing a multicopy vector, so that it appears that the ice nucleating activity is associated with enhanced expression of the genes encoding for the INA.
In order to demonstrate the subject invention, the following experiments were carried out.
EXPERIMENTAL
. . .
Methods Three strains were employed as sources for DNA
encoding for INA: Pseudomonas syringae (two strains:c.it-7 and 31rif-1) and Erwlnla herbicola (one skrain:26SR6~2).
The DNA from the strains was extracted, purified by two cycles of CsCl-ethidium bromide density gxadient centrifuga-tion, freed of ethidium bromide, dialyzed against appro-priate buffers, partially digested with EcoRI and frac~
tionated by a 5-25 neutral sucrose gradient centrifugation.
The partial digestion employed 0.3 units EcoRI per l~g DNA
following the directions of the supplier (Bethesda, Research Laboratories, Md.) and the reaction ~uenched after 0.5hr by heating at 65C for 2min. Fractions obtained from the sucrose gradient were analyzed by agarose gel electrophor-esis and those rich in fragments in the 18-25kb range were pooled and ligated to the cosmid vector pLAFRl, previously linearized with EcoRI. (pL~FR was supplied by S. Long).
The plasmid pLAFRl is a derivative of the vector pRK290 (Tcr) that contains the cos sites of phage A for ln vitro packaging. pLAFRl was obtained by inserting a BglII
fragment from pHC79 (Hohn and Collins, Gene (1980) 11:291-298) into th~ BglII site of pRK290. The plasmid is-a broad host range oligocopy vector with a single EcoRI site outside the Tc gene. There is no selection or screening for insertional inactivation in pRK290. However, the pLAFR1 derivative is very useful because it requires inserts of a minimum size for packaging and therefore selects automa-tically for inserts of about 18-30kb in length.
Ligation of the DNA fragments in pLAFRl is achieved using T4 ligase following the supplier's directions (Bethesda Research Labs.). A relatively high ratio of foxeign DN~ fragments to linearized vector i~ employed, about 3-4:1/ to minimize dimerization of the vector. About
3-4~g of DNA fragments is employed per l~g of linearized pLAFR1. The DNA fragments are ligated in buffer brought to 10~1 with water, after being heated for 5min at 65C, 30min at 42C and then allowed to set for 2hrs at room tempera-ture. The annealed mixture is made lmM ATP and 1 unik T4 ligase added and the mixture incubated at 12C overnight.
The ligated mixture was packaged ln vitro and transduced i~to E. coli HB101. Packaging is achieved in accordance with the procedure described by Hohn, M: In Vitro Packaging of A and Cosmid ~NA, Wu ed. Methods in Enz~mo-logy, vol. 68, Academic Press, N.Y., pages 299-309, 1979.
Approximately 30~1 A heads and 20~1 A tails are combined with 2~1 lM ATP and 5~1 ligation reaction mixture and the resulting mixture incubated for lhr at room temperature. To the mixture is then added buffer lOmM tris, pH 7.6, lOmM
MgC12 to provide the phage stock which is employed for transduction.
The transduction was accomplished by combining O.lml of the phage stock with 0.5ml of E. coli HB101 (107-108 cells/ml, mid-log growth) in Luria broth 0.4%
maltose, and incubating for one hour at 37C. The mixture was diluted with 2ml Luria broth and incubated for 1.5-2hrs.
The cells were then plated on agar medium (Luria agar) supplemented with tetracycline ~lO~g/ml) and incubated for 1-2 days.
The colonies on several of the plates were screened for ice nucleation activity (INA) by transferring to velvet pads which were replica-printed onto sheets of aluminum foil precoated with a thin coating of paraffin.
The foils were bent upwards at the edges, placed on a cir-culating alcohol-bath, adjusted to -5 and -9C and the cells on the paraffin-coated foil sprayed with water micro-droplets. Microdroplets that are in contact with INA cellsfreeze, giving a frosty appearance to INA colonies.
Several INA colonies were identified in each library and purified.
The spectrum or profile of ice nuclei to tempera-ture is determined by placing a plurality of bacteria-con-~aining water droplets (10 ~1) on a paraffin-coated temp-; erature controlled aluminum block, where the temperature is ~z~
slowly lowered (~0.2C/min) and -the cumulative number of droplets which freeze are counted. The numbex of cells per droplet can be varied by serial dilution. The nu~ber of ice nuclei is calculated from the number of fro~en droplets at each temperakure and is plotted aga1nst temperature at var-ious cell concentrations. The log of ice nuclei/cell is plotted against temperature and usually shows two plakeaus, one in the region of -4 to -7C and one below -9C.
Results All INA~ E. coli transductants contained recom-binant plasmids, each having a different EcoRI fragment, but with one common fragment corresponding to the vector used in the plasmid construction. Some of the recombinant plasmids were introduced into E. coli (SK1592) and HB101 and to INA
mutants of the "DNA source strainl' used in their construc-tion (P. syringae, cit-7 and E. herbicola 26SR6-2) by trans-formation and/or mobilization. In all cases INA progeny were obtained. The above results demonstrate that the cloned DNA fragments encode for expression of the INA
phenotype in the strains of origin and are capable of ex-pressing the phenotype in a heterologous INA cellular environment, such as E. coli.
A particular plasmid pC-l was isolated and used in a number of experiments. pC-l contained a ~3.2kb partially digested EcoRI fragment from the strain P. syringae cit-7 and inserted into the unique EcoRI site of pLAFRl. The ice nucleation spectrum (see Methods) of E. coli carrying the plasmid pC-1 was compared with that of P. syrin~ae cit-7 strain and the spectra found to be essentially identical. A
lOkb EcoRI fragmenk from the pC-1 insert was subcloned in the unigue EcoRI site of the multicopy vector pBR325. This site is in the chloramphenicol acetyltransferase gene. The resulting plasmid, designated pClBR1 upon EcoRI restriction showed the restriction fragments expected of pBR325 carrying a single EcoRI insert (approximately lOkb) which was present in pC-l and confers INA~ phenotype to E. coli. The fre-~L26~
~uency of ice nucleation (cell/nuclei) by E. coli HB101 (pC-l~ and E. coli ~IB101 (pCl~R1) after gxowth at 23VC
(optimal for expression of INA in wild type strains) and at 37C was compared. (Although wild type P. ~y~ does not grow at 37C, it is known that growkh temperatures higher than 24C strongly reduce ice nucleation ~requency.~ Cells were assayed for ice nucleation frequency after 24 and 49 hours of growth (expression of INA wild type INA strains increases greatly at late states of growth cycle). The 0 following table indicates the results.
cells/nuclei -5C -9C~
_. syringae Cit 7 4.13E2 1.92E2 E. coli HB101 (pC-l) 1.43E4 2.56E2 E. coli HB101 ~pCIBR1) 5.65E1 2.07 E. herbicola 26SR6-2 5.247E5 7.27E2 E. coli HB101 (pE-7) 8.27E3 9.02E2 E. coli HB101* -- 0 0 48 hour old cultures grown on KB Tc(15~g/ml) or KB (KB=Kings B medium) Ej=10]
pLAFR1 with E. herbicola DNA fragment The above data indicate that: ~1) the expression of INA activity in E. coli is under similar temperature and temporal control as in wild ~ype strains; and t2~ cloning in a multicopy vector results in substantially greater ice nucleation fre~uency (i.e. a much greater proportion of cells result that contain activP ice nuclei). Based on these experiments, this affect cannot be exclusively attri-buted to the "copy number effect," resulting in more effi-cient expression of the cloned genes (the EcoRI fragment and pClBR1 is inserted within the chloramphenicol acetyl-transferase encoding se~uence of pBR325) or to the elimina-tion of repressor-type regulatory elements during the sub-cloning of the active fragment from pC-l. The level of expression of INA in E. coli HB101 (pClBRl) i~ ~
cells/nuclei, which is at or near the limit o~ the assay me-thods used.
It is evident from the above re~ults ~hat ice nucleation activity can be transferred to a wide range o hosts which have previously not had this capability. This does not preclude the introduction of said DN~ fragments to INA~ hosts to obtain for example, increased expression of INA through the use of a multicopy vector. A relatively small DNA fra~ment is required which can easily be intro-duced into a wide range of organisms and cells, either in single or multicopy form, either remaining extrachromosomal or being integrated, and providing for INA phenotype.
Thus, organisms which have a wide variety of ecological niches can be modified so as to provide for ice nucleation activity in new environments and/or with higher efficiency.
Organisms that are more efficient with respect to INA ex-pression are also attractive candidates for use for weather modification.
Although the foregoing invention has been des-cribed in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
The ligated mixture was packaged ln vitro and transduced i~to E. coli HB101. Packaging is achieved in accordance with the procedure described by Hohn, M: In Vitro Packaging of A and Cosmid ~NA, Wu ed. Methods in Enz~mo-logy, vol. 68, Academic Press, N.Y., pages 299-309, 1979.
Approximately 30~1 A heads and 20~1 A tails are combined with 2~1 lM ATP and 5~1 ligation reaction mixture and the resulting mixture incubated for lhr at room temperature. To the mixture is then added buffer lOmM tris, pH 7.6, lOmM
MgC12 to provide the phage stock which is employed for transduction.
The transduction was accomplished by combining O.lml of the phage stock with 0.5ml of E. coli HB101 (107-108 cells/ml, mid-log growth) in Luria broth 0.4%
maltose, and incubating for one hour at 37C. The mixture was diluted with 2ml Luria broth and incubated for 1.5-2hrs.
The cells were then plated on agar medium (Luria agar) supplemented with tetracycline ~lO~g/ml) and incubated for 1-2 days.
The colonies on several of the plates were screened for ice nucleation activity (INA) by transferring to velvet pads which were replica-printed onto sheets of aluminum foil precoated with a thin coating of paraffin.
The foils were bent upwards at the edges, placed on a cir-culating alcohol-bath, adjusted to -5 and -9C and the cells on the paraffin-coated foil sprayed with water micro-droplets. Microdroplets that are in contact with INA cellsfreeze, giving a frosty appearance to INA colonies.
Several INA colonies were identified in each library and purified.
The spectrum or profile of ice nuclei to tempera-ture is determined by placing a plurality of bacteria-con-~aining water droplets (10 ~1) on a paraffin-coated temp-; erature controlled aluminum block, where the temperature is ~z~
slowly lowered (~0.2C/min) and -the cumulative number of droplets which freeze are counted. The numbex of cells per droplet can be varied by serial dilution. The nu~ber of ice nuclei is calculated from the number of fro~en droplets at each temperakure and is plotted aga1nst temperature at var-ious cell concentrations. The log of ice nuclei/cell is plotted against temperature and usually shows two plakeaus, one in the region of -4 to -7C and one below -9C.
Results All INA~ E. coli transductants contained recom-binant plasmids, each having a different EcoRI fragment, but with one common fragment corresponding to the vector used in the plasmid construction. Some of the recombinant plasmids were introduced into E. coli (SK1592) and HB101 and to INA
mutants of the "DNA source strainl' used in their construc-tion (P. syringae, cit-7 and E. herbicola 26SR6-2) by trans-formation and/or mobilization. In all cases INA progeny were obtained. The above results demonstrate that the cloned DNA fragments encode for expression of the INA
phenotype in the strains of origin and are capable of ex-pressing the phenotype in a heterologous INA cellular environment, such as E. coli.
A particular plasmid pC-l was isolated and used in a number of experiments. pC-l contained a ~3.2kb partially digested EcoRI fragment from the strain P. syringae cit-7 and inserted into the unique EcoRI site of pLAFRl. The ice nucleation spectrum (see Methods) of E. coli carrying the plasmid pC-1 was compared with that of P. syrin~ae cit-7 strain and the spectra found to be essentially identical. A
lOkb EcoRI fragmenk from the pC-1 insert was subcloned in the unigue EcoRI site of the multicopy vector pBR325. This site is in the chloramphenicol acetyltransferase gene. The resulting plasmid, designated pClBR1 upon EcoRI restriction showed the restriction fragments expected of pBR325 carrying a single EcoRI insert (approximately lOkb) which was present in pC-l and confers INA~ phenotype to E. coli. The fre-~L26~
~uency of ice nucleation (cell/nuclei) by E. coli HB101 (pC-l~ and E. coli ~IB101 (pCl~R1) after gxowth at 23VC
(optimal for expression of INA in wild type strains) and at 37C was compared. (Although wild type P. ~y~ does not grow at 37C, it is known that growkh temperatures higher than 24C strongly reduce ice nucleation ~requency.~ Cells were assayed for ice nucleation frequency after 24 and 49 hours of growth (expression of INA wild type INA strains increases greatly at late states of growth cycle). The 0 following table indicates the results.
cells/nuclei -5C -9C~
_. syringae Cit 7 4.13E2 1.92E2 E. coli HB101 (pC-l) 1.43E4 2.56E2 E. coli HB101 ~pCIBR1) 5.65E1 2.07 E. herbicola 26SR6-2 5.247E5 7.27E2 E. coli HB101 (pE-7) 8.27E3 9.02E2 E. coli HB101* -- 0 0 48 hour old cultures grown on KB Tc(15~g/ml) or KB (KB=Kings B medium) Ej=10]
pLAFR1 with E. herbicola DNA fragment The above data indicate that: ~1) the expression of INA activity in E. coli is under similar temperature and temporal control as in wild ~ype strains; and t2~ cloning in a multicopy vector results in substantially greater ice nucleation fre~uency (i.e. a much greater proportion of cells result that contain activP ice nuclei). Based on these experiments, this affect cannot be exclusively attri-buted to the "copy number effect," resulting in more effi-cient expression of the cloned genes (the EcoRI fragment and pClBR1 is inserted within the chloramphenicol acetyl-transferase encoding se~uence of pBR325) or to the elimina-tion of repressor-type regulatory elements during the sub-cloning of the active fragment from pC-l. The level of expression of INA in E. coli HB101 (pClBRl) i~ ~
cells/nuclei, which is at or near the limit o~ the assay me-thods used.
It is evident from the above re~ults ~hat ice nucleation activity can be transferred to a wide range o hosts which have previously not had this capability. This does not preclude the introduction of said DN~ fragments to INA~ hosts to obtain for example, increased expression of INA through the use of a multicopy vector. A relatively small DNA fra~ment is required which can easily be intro-duced into a wide range of organisms and cells, either in single or multicopy form, either remaining extrachromosomal or being integrated, and providing for INA phenotype.
Thus, organisms which have a wide variety of ecological niches can be modified so as to provide for ice nucleation activity in new environments and/or with higher efficiency.
Organisms that are more efficient with respect to INA ex-pression are also attractive candidates for use for weather modification.
Although the foregoing invention has been des-cribed in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
Claims (20)
1. A microorganism cell having enhanced ice nucleation activity as a result of introducing into said cell or a parent of said cell a DNA sequence encoding for ice nucleation active substance(s).
2. A microorganism cell according to claim 1, wherein said cell is prokaryotic and said DNA sequence is from a heterologous source in relation to said cell.
3. A microorganism cell according to claim 1, wherein said cell is eukaryotic and said DNA sequence is from a heterologous source in relation to said cell.
4. A microorganism cell according to claim 1, wherein said DNA sequence is on an extrachromosomal ele-ment.
5. A microorganism cell according to claim 1, wherein said DNA sequence is integrated into the chromo-some of said microorganism cell.
6. E. coli having ice nucleation activity as a result of introducing into said cell or parent of said cell a DNA sequence encoding for ice nucleation active substance(s).
7. E. coli according to claim 6, wherein said ice nucleation activity results from a gene carried on an extrachromosomal element.
8. A DNA sequence of less than about 10kb encoding for ice nucleation activity.
9. A DNA sequence according to claim 8, wherein said sequence is derived from the species Pseudomonas or Erwinia or Xanthomonas.
10, A functional self-replicating extrachromoso-mal element having an intact replicon and a DNA sequence capable of expression, according to claim 8.
11. An element according to claim 10, wherein said replicon is recognized by a prokaryotic host.
12. An element according to any of claims 10 or 11, wherein said DNA sequence is derived from Pseudomonas or Erwinia.
13. A method for enhancing ice nucleation acti-vity of a microorganism cell, which comprises:
introducing into said cell a DNA sequence encoding for ice nucleation activity under conditions where said DNA sequence is expressed; and growing cells which contain said DNA sequence.
introducing into said cell a DNA sequence encoding for ice nucleation activity under conditions where said DNA sequence is expressed; and growing cells which contain said DNA sequence.
14. A method according to claim 13, wherein said DNA sequence is a plasmid insert and is introduced by transformation as part of said plasmid.
15. A method according to claim 13, wherein said DNA sequence is a cosmid insert and is introduced by trans-duction as a part of said cosmid.
16. A method according to claim 13 wherein said cell is a prokaryote lacking ice nucleation activity.
17. A method according to claim 16, wherein said cell is derived from a strain in which the wild-type strains lack ice nucleation activity.
18. A method according to claim 17, wherein said cell is E. coli.
19. A method for preventing supercooling of an aqueous medium which comprises:
introducing microorganism cells according to claim 1 into said aqueous medium, at or before the time said aqueous medium is cooled to a temperature at or below freezing.
introducing microorganism cells according to claim 1 into said aqueous medium, at or before the time said aqueous medium is cooled to a temperature at or below freezing.
20. A method according to claim 19, including the additional step of blowing the cell containing aqueous medium at a temperature of about freezing or below to form snow.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000430877A CA1212641A (en) | 1983-06-21 | 1983-06-21 | Ice nucleating microorganisms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000430877A CA1212641A (en) | 1983-06-21 | 1983-06-21 | Ice nucleating microorganisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1212641A true CA1212641A (en) | 1986-10-14 |
Family
ID=4125522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000430877A Expired CA1212641A (en) | 1983-06-21 | 1983-06-21 | Ice nucleating microorganisms |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1212641A (en) |
-
1983
- 1983-06-21 CA CA000430877A patent/CA1212641A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU563310B2 (en) | Novel ice nucleating microorganisms | |
| US4760022A (en) | Stabilized plasmids | |
| Ditta | Tn5 mapping of Rhizobium nitrogen fixation genes | |
| EP0155189A2 (en) | Expression of cell wall degrading proteins and host cells harboring dna encoding such protein | |
| US4920054A (en) | Shuttle vectors from rhodococcus equi | |
| Mercado-Blanco et al. | Stability and transmissibility of the cryptic plasmids of Rhizobium meliloti GR4: their possible use in the construction of cloning vectors for rhizobia | |
| US5891692A (en) | Method for increasing the viability and transformation ability of bacteria during or after storage at low temperatures | |
| CA1212641A (en) | Ice nucleating microorganisms | |
| Wu et al. | Analysis of Escherichia coli K12 F factor transfer genes: traQ, trbA, and trbB | |
| JPH07322876A (en) | Microorganism variant having ice nucleus forming activity atnormal temperature and production of snow or ice using the same | |
| JPH09173077A (en) | Ultrathermoresistant acidic alpha-amylase and dna fragment containing gene for producing the alpha-amylase | |
| DE19523560A1 (en) | Sucrose metabolism mutants | |
| JPS62122585A (en) | Host-vector system | |
| NO165446B (en) | PROCEDURE FOR AA GENERATING OR ENHANCING IS NUCLEARING ACTIVITY OF PROKARYOTIC MICROORGANISM CELLS. | |
| CN111690580B (en) | Recombinant escherichia coli for producing ice nucleoprotein, construction method and application thereof | |
| Yanase et al. | Expression of the Escherichia coli α-galactosidase and lactose permease genes in Zymomonas mobilis and its raffinose fermentation | |
| US5308765A (en) | Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically acitve carboxylic acids and their enantiomeric esters using said transformants | |
| US5149644A (en) | Process for the release of poly(3-hydroxy carboxylic acids) | |
| FI85721C (en) | Method for extracellular production of penicillinase, plasmid used in the method and method for constructing the plasmid | |
| Hasegawa et al. | Cloning of bacterial ice nucleation genes of Pseudomonas viridiflava in Escherichia coli | |
| US4970149A (en) | Class II restriction endonuclease Ksp632I, a process for obtaining it and the use thereof | |
| KR100705338B1 (en) | Microorganism having improved ice nucleating activity and method for preparing thereof | |
| Ohgama et al. | Expression of the ice nucleation active gene of a novel plasmid pNVR-1 from Pseudomonas viridiflava in Escherichia coli and Pseudomonas aeruginosa | |
| SU1659480A1 (en) | Strain of bacterium klebsiella pneumoniae - a producer of restrictase kpn 378 1 | |
| RU2314346C2 (en) | Plasmids for chromosome recombination of escherichia coli |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |